tradmap

GPAT Financials GP-Act III Acquisition Corp.

3 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Net income
-$14041 $6M $12M $0 2023 2024 2025
Net income
Return on equity & assets (ROE / ROA)
-82% -34% 14% 0% 2023 2024 2025
ROEROA
Shareholders' equity (book value)
-$14M -$7M $0 2023 2024 2025
Equity
Free cash flow (CFO − capex)
$0 $1 $1 2023 2024 2025
Free cash flow
Cash vs total debt
$0 $241786 $483572 2023 2024 2025
CashTotal debt
Cash flow: operating / investing / financing
-$288M $533541 $289M $0 2023 2024 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $12M -82.1% 3.8% $112660
2024 $9M -62.2% 2.9% $483572
2023 -$14041 14.3% -2.6% $1208

Valuation over time

How the market has priced GPAT against its own fundamentals since 2024-07 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 3.8 7.7 Jul '24 Nov '24 Mar '25 Jul '25 Nov '25 Mar '26 Jul '26
P/E

Frequently asked questions

Is GPAT growing its revenue and profit?

See the revenue and net-income charts above for GP-Act III Acquisition Corp.'s multi-year trend.

How much debt does GPAT have?

As of FY2025, GP-Act III Acquisition Corp. reported — of total debt against $112660 of cash.

What is GPAT's profit margin?

In FY2025, gross margin was —, operating margin —, and net margin —.

What is GPAT's P/E ratio?

As of Sep '26, GP-Act III Acquisition Corp. traded at a price-to-earnings ratio of about 5.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.